Search Results - "MOWLES, Delores"

Refine Results
  1. 1
  2. 2

    Role of Human Nucleoside Transporters in the Uptake and Cytotoxicity of Azacitidine and Decitabine by Damaraju, Vijaya L., Mowles, Delores, Yao, Sylvia, Ng, Amy, Young, James D., Cass, Carol E., Tong, Zeen

    Published in Nucleosides, nucleotides & nucleic acids (01-03-2012)
    “…The nucleoside analogs 5-azacytidine (azacitidine) and 5-aza-2′-deoxycytidine (decitabine) are active against acute myeloid leukemia and myelodysplastic…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Comparative in vitro evaluation of transportability and toxicity of capecitabine and its metabolites in cells derived from normal human kidney and renal cancers by Damaraju, Vijaya L, Mowles, Delores, Wilson, Marnie, Kuzma, Michelle, Cass, Carol E, Sawyer, Michael B

    Published in Biochemistry and cell biology (01-12-2013)
    “…The goal of this study was to understand roles of nucleoside and nucleobase transport processes in capecitabine pharmacology in cells derived from human renal…”
    Get more information
    Journal Article
  5. 5
  6. 6
  7. 7

    Role of human nucleoside transporters in the cellular uptake of two inhibitors of IMP dehydrogenase, tiazofurin and benzamide riboside by Damaraju, Vijaya L, Visser, Frank, Zhang, Jing, Mowles, Delores, Ng, Amy M L, Young, James D, Jayaram, Hiremagalur N, Cass, Carol E

    Published in Molecular pharmacology (01-01-2005)
    “…Benzamide riboside (BR) and tiazofurin (TR) are converted to analogs of NAD that inhibit IMP dehydrogenase (IMPDH), resulting in cellular depletion of GTP and…”
    Get more information
    Journal Article
  8. 8

    Differential Transport of Cytosine-Containing Nucleosides by Recombinant Human Concentrative Nucleoside Transporter Protein hCNT1 by Graham, Kathryn A., Leithoff, Jackie, Coe, Imogen R., Mowles, Delores, Mackey, John R., Young, James D., Cass, Carol E.

    Published in Nucleosides, nucleotides & nucleic acids (01-01-2000)
    “…The transportability of cytosine-containing nucleosides by recombinant hCNT1 was investigated in transfected mammalian cells. Apparent K m values for…”
    Get full text
    Journal Article
  9. 9

    Erlotinib, Gefitinib, and Vandetanib Inhibit Human Nucleoside Transporters and Protect Cancer Cells from Gemcitabine Cytotoxicity by DAMARAJU, Vijaya L, SCRIVER, Tara, MOWLES, Delores, KUZMA, Michelle, RYAN, Anderson J, CASS, Carol E, SAWYER, Michael B

    Published in Clinical cancer research (2014)
    “…Combinations of tyrosine kinase inhibitors (TKI) with gemcitabine have been attempted with little added benefit to patients. We hypothesized that TKIs designed…”
    Get full text
    Journal Article
  10. 10

    Interactions of multitargeted kinase inhibitors and nucleoside drugs: Achilles heel of combination therapy? by Damaraju, Vijaya L, Kuzma, Michelle, Mowles, Delores, Cass, Carol E, Sawyer, Michael B

    Published in Molecular cancer therapeutics (01-01-2015)
    “…Multitargeted tyrosine kinase inhibitors (TKI) axitinib, pazopanib, and sunitinib are used to treat many solid tumors. Combination trials of TKIs with…”
    Get full text
    Journal Article
  11. 11

    Abstract 797: Interaction of multitargeted tyrosine kinase inhibitors with human nucleoside transporters by Damaraju, Vijaya L., Kuzma, Michelle, Mowles, Delores, Cass, Carol E., Sawyer, Michael B.

    Published in Cancer research (Chicago, Ill.) (01-10-2014)
    “…Abstract Several oral multitargeted kinase (MTK) inhibitors are approved for use in the clinic among which, axitinib, pazopanib and sunitinib are used to treat…”
    Get full text
    Journal Article
  12. 12

    Two Distinct Molecular Mechanisms Underlying Cytarabine Resistance in Human Leukemic Cells by JIE CAI, DAMARAJU, Vijaya L, GROULX, Normand, MOWLES, Delores, YUNSHAN PENG, ROBINS, Morris J, CASS, Carol E, GROS, Philippe

    Published in Cancer research (Chicago, Ill.) (01-04-2008)
    “…To understand the mechanism of cellular resistance to the nucleoside analogue cytarabine (1-beta-D-arabinofuranosylcytosine, AraC), two resistant derivatives…”
    Get full text
    Journal Article
  13. 13

    Effects of gefitinib and vandetanib on human equilibrative nucleoside transporter 1 and on gemcitabine cytotoxicity by Damaraju, Vijaya L., Scriver, Tara, Mowles, Delores, Cass, Carol E, Sawyer, Michael B.

    Published in Journal of clinical oncology (20-05-2013)
    “…Abstract only 2546 Background: Combination chemotherapy with tyrosine kinase inhibitors (TKIs) and gemcitabine has been attempted with little added benefit to…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines by MACKEY, J. R, MANI, R. S, SELNER, M, MOWLES, D, YOUNG, J. D, BELT, J. A, CRAWFORD, C. R, CASS, C. E

    Published in Cancer research (Chicago, Ill.) (01-10-1998)
    “…Gemcitabine (2',2'-difluorodeoxycytidine) is a novel pyrimidine nucleoside drug with clinical efficacy in several common epithelial cancers. We have proposed…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Influence of Sugar Ring Conformation on the Transportability of Nucleosides by Human Nucleoside Transporters by Damaraju, Vijaya L., Mowles, Delores, Smith, Kyla M., Yao, Sylvia Y. M., Young, James D., Marquez, Victor E., Cass, Carol E.

    “…The conformational preference of human nucleoside transporters (hNTs) with respect to sugar ring was examined using conformationally fixed purine and…”
    Get full text
    Journal Article
  18. 18

    Cytotoxic activity of gemcitabine in cultured cell lines derived from histologically different types of bladder cancer: Role of thymidine kinase 2 by Damaraju, Swathi, Damaraju, Vijaya L., Mowles, Delores, Sawyer, Michael B., Damaraju, Sambasivarao, Cass, Carol E.

    Published in Biochemical pharmacology (01-01-2010)
    “…World wide incidence of bladder cancer is rising with nearly 13,760 deaths attributed to bladder cancer in 2007 in the USA. Tumor types of the urothelium…”
    Get full text
    Journal Article
  19. 19

    Nucleoside transporter gene expression in wild-type and mENT1 knockout mice by Graham, Kathryn, Yao, Sylvia, Johnson, Lorelei, Mowles, Delores, Ng, Amy, Wilkinson, Jodi, Young, James D, Cass, Carol E

    Published in Biochemistry and cell biology (01-04-2011)
    “…Owing to the overlapping and redundant roles of the seven mammalian nucleoside transporters (NTs), which belong to two protein families (ENTs and CNTs), the…”
    Get more information
    Journal Article
  20. 20

    The role of human nucleoside transporters in cellular uptake of 4'-thio-beta-D-arabinofuranosylcytosine and beta-D-arabinosylcytosine by Clarke, Marilyn L, Damaraju, Vijaya L, Zhang, Jing, Mowles, Delores, Tackaberry, Tracey, Lang, Thach, Smith, Kyla M, Young, James D, Tomkinson, Blake, Cass, Carol E

    Published in Molecular pharmacology (01-07-2006)
    “…4'-Thio-beta-D-arabinofuranosyl cytosine (TaraC) is in phase I development for treatment of cancer. In human equilibrative nucleoside transporter (hENT)…”
    Get more information
    Journal Article